isocarboxazid has been researched along with Amyotonia Congenita in 1 studies
Isocarboxazid: An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kirrane, R | 1 |
| Bodner, R | 1 |
| Lynch, T | 1 |
1 other study available for isocarboxazid and Amyotonia Congenita
| Article | Year |
|---|---|
Response to "Sertraline and isocarboxazid cause a serotonin syndrome".
Topics: 1-Naphthylamine; Adult; Dextromethorphan; Drug Therapy, Combination; Female; Humans; Isocarboxazid; | 1995 |